Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients

British Journal of Cancer

Volumn 78, Issue 7, 1998, Pages 922-927

  Shayeghi, M ^a   Seal, S ^a   Regan, J ^b   Collins, N ^a   Barfoot, R ^a   Rahman, N ^a   Ashton, A ^c   Moohan, M ^a   Wooster, R ^a   Owen, R ^c   Bliss, J M ^a   Stratton, M R ^a   Yarnold, J ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

Author keywords

Ataxia telangiectasia; ATM; Breast cancer; Radiation sensitivity

Indexed keywords

ARTICLE; ATAXIA TELANGIECTASIA; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE MUTATION; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION INJURY; RADIOSENSITIVITY; RANDOMIZED CONTROLLED TRIAL;

EID: 7344226182     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.602     Document Type: Article

References (26)

1. Appleby JM, Barber JBP, Levine E, Varley JM, Taylor AMR, Stankovic T, Heighway J, Warren C and Scott D (1997) Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br J Cancer 76: 1546-1549
2. Athma P, Rappaport R and Swift M (1996) Molecular genotyping shows that ataxia telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 92: 130-134
3. Bishop DT and Hopper J (1997) AT-tributable risks? Nature Genet 15/3: 226
4. Boder E and Sedgwick RP (1958) Ataxia telangiectasia: a familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection. Pediatrics 21: 526-554
5. Byrd PJ, McConville CM, Cooper P, Parkhill J, Stankovic T, McGuire GM. Thick JA and Taylor MR (1996) Mutations revealed by sequencing the 5′ half of the gene for the ataxia telangiectasia. Hum Mol Genet 5: 145-149
6. Easton DF (1994) Cancer risks in AT heterozygotes. Int J Radiat Biol 66 (suppl. 6): s177-182
7. FitzGerald MG, Bean JM, Hedge SR, Unsal H, MacDonald DJ, Harkin DP, Finkelstein DM, Isselbacher KJ and Haber DA (1997) Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nature Genet 15: 307-310
8. Ganguly A, Rock MJ and Prockop DJ (1993) Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments. Proc Natl Acad Sci USA 90: 10325-10329
9. Gilad S, Khosravi R, Shkedy D, Uziel T, Ziv Y, Savitsky K, Rotman G, Smith S, Chessa L, Jorgensen TJ, Harnik R, Frydman M, Sanal O, Portnoi S, Goldwicz Z, Jaspers NGJ, Gatti RA, Lenoir G, Lavin MF, Tatsumi K, Wegner RD, Shiloh Y and Barshira A (1996) Predominance of null mutations in ataxia telangiectasia. Hum Mol Genet 5: 433-439
10. Gotoff SP, Amirnokri E and Liebner EJ (1967) Ataxia telangiectasia neoplasia, untoward response to x-radiation and tuberous sclerosis. Am J Dis Child 114: 617-627
11. Johansen J, Bentzen SM and Overgaard J (1996) Relationship between the in-vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother Oncol 40: 101-109
12. Jorgensen TJ and Shiloh Y (1996) The ATM gene and the radiobiology of ataxia telangiectasia. Int J Radiat Biol 69: 527-537
13. Maher Committee (1995) Management of Adverse Effects Following Breast Radiotherapy. London: Royal College of Radiologists
14. Nagasawa H, Kraemer KH, Shiloh Y and Little JB (1987) Detection of ataxia telangiectasia heterozygous cell lines by post-irradiation cumulative labelling index: measurements with coded samples. Cancer Res 47: 398-402
15. Owen JR, Yarnold JR, Bliss JM, Ebbs SR, Regan J, Harrington G and Ashton A (1996) RT fractionation sensitivity: proposals for a UK national trial. Radiother Oncol Suppl. 1: 572
16. Pippard EC, Hall AJ, Barker DJP and Bridges BA (1988) Cancer in homozygotes and heterozygotes of ataxia telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 48: 2929-2932
17. Ramsey J, Birrell G, Lavin M (1996) Breast cancer and radiotherapy in ataxia telangiectasia heterozygote. Lancet 347: 1627
18. Savitsky K, Bar-Shira A, Gilad S, Rothman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel D, Skez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGT, Taylor AMR, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS and Shiloh Y (1995) A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753
19. Swift M, Reitnauer PJ, Morrell D and Chase CL (1987) Breast and other cancers in families with ataxia telangiectasia. New Engl J Med 316: 1289-1294
20. Swift M, Morrell D, Massey RB and Chase CL (1991) Incidence of cancer in 161 families affected by ataxia telangiectasia. New Engl J Med 325: 1831-1836
21. Taylor AM, Harnden DG, Arlett CF, Harcourt SA, Lehmann AR, Stevens S and Bridges BA (1975) Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature 258(5534): 427-429
22. Tucker SL, Turesson I and Thames HD (1992) Evidence for individual differences in the radiosensitivity of human skin. Eur J Cancer 28A: 1283-1291
23. Turesson I (1989) The progression rate of late radiation effects in normal tissue and its impact on dose-response relationships. Radiotherapy 15: 217-226
24. Turesson I (1990) Individual variation and dose dependency in the progression rate of skin telangiectasia. Int J Radiat Oncol Biol Phys 19: 1569-1574
25. Weeks DE, Paterson MC, Lange K, Andrais B, Davies RC, Yoder F and Gatti RA (1991) Assessment of chronic radiosensitivity as an in vitro assay for identification of ataxia telangiectasia. Radiat Res 128: 90-99
26. West CM, Elyan SA, Berry P, Cowan R and Scott D (1995) A comparison of the radiosensitivity of lymphcytes from normal donors, cancer patients, individuals with ataxia telangiectasia (AT) and AT heterozygotes. Int J Radiat Biol 68(2): 197-203